Amrita Basu
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 3
- Peptidase Inhibition and Analysis 3
-
- Ubiquitin and proteasome pathways 5
- Co-authors
- Krithika N. Kodumudi (13 shared papers)Brian J. Czerniecki (12 shared papers)Ganesan Ramamoorthi (9 shared papers)Jo Freeman (1 shared paper)Colin Snyder (5 shared papers)Amber Beyer (3 shared papers)Corey Gallen (3 shared papers)Gary K. Koski (3 shared papers)
- Journals
- Cancer Research (5 papers)Frontiers in Immunology (3 papers)Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesIndiaChina
In The Last Decade
Amrita Basu
55 papers receiving 976 citations
Amrita Basu's Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 295
- Immunology 235
- Cancer Research 78
- Molecular Biology 364
- Gender Studies 51
Countries citing papers authored by Amrita Basu
This map shows the geographic impact of Amrita Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amrita Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amrita Basu more than expected).
Fields of papers citing papers by Amrita Basu
This network shows the impact of papers produced by Amrita Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amrita Basu. The network helps show where Amrita Basu may publish in the future.
Co-authors
The 25 scholars most cited alongside Amrita Basu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy Hit paper breakdown → | 2021 | 237 |
| 2 | 2009 | 104 | |
| 3 | 1996 | 83 | |
| 4 | 2019 | 81 | |
| 5 | 2021 | 67 | |
| 6 | 2021 | 43 | |
| 7 | 2019 | 42 | |
| 8 | 2013 | 37 | |
| 9 | Violence and democracy in India | 2007 | 32 |
| 10 | 2021 | 28 | |
| 11 | 2010 | 27 | |
| 12 | 2018 | 27 | |
| 13 | 2017 | 24 | |
| 14 | 2003 | 24 | |
| 15 | 2018 | 23 | |
| 16 | 2022 | 19 | |
| 17 | 2015 | 14 | |
| 18 | 1999 | 13 | |
| 19 | 2021 | 9 | |
| 20 | 2021 | 8 |
About Amrita Basu
Amrita Basu is a scholar working on Oncology, Molecular Biology, Immunology, Philosophy and Cancer Research, having authored 64 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (7 papers), Indian History and Philosophy (7 papers), Ubiquitin and proteasome pathways (5 papers), South Asian Studies and Conflicts (5 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (295 citations), Immunology (235 citations), Cancer Research (78 citations), Molecular Biology (364 citations) and Gender Studies (51 citations). Amrita Basu has collaborated with scholars based in United States, India and China. Frequent co-authors include Krithika N. Kodumudi, Brian J. Czerniecki, Ganesan Ramamoorthi, Jo Freeman, Colin Snyder, Amber Beyer, Corey Gallen, Gary K. Koski, Gabriella Albert and Mary L. Disis. Their work appears in journals such as Cancer Research, Frontiers in Immunology, Journal of Clinical Oncology, Annals of Oncology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.